Global Unique Device Identification Database (GUDID) Draft Guidance for Industry

By Center for Devices and Radiological Health, Informatics Staff, U.S. Department of Health and Human Services Food and Drug Administration, AHRMM
This document is intended to provide information about submitting data to the database for device Labelers, entities responsible for providing the data to the GUDID.
 

Related Resources

Advisory
Special Fraud Alert: Physician-Owned Entities
This Special Fraud Alert focuses on the specific attributes and practices of PODs that OIG believes produce substantial fraud and abuse risk and pose…
Issue Brief
Medical Device Excise Tax - What You Should Know
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
AHRMM Leading Practice Statement on Supply Chain Integration
As a Leading Practice, the AHRMM Board of Directors adopts that Supply Chain Services be fully integrated into high cost clinical services…
Advisory
Medical Device Tax Next Steps
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Advisory
Statement on Pricing Transparency
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Letter/Comment
AHRMM Statement on Comparative Effectiveness
AHRMM supports the concept and use of Comparative Effectiveness Research (CER) to provide evidence-based data to help inform purchasing decis